{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:57:45Z","timestamp":1791482265574,"version":"4.3.4"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.prp.2016.12.023","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T15:38:30Z","timestamp":1483630710000},"page":"585-589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Follicular lymphoma in situ in the spleen of a patient with autoimmune hemolytic anemia and carrying HCV was associated with more clonal B-cells than t(14;18) positive B-cells"],"prefix":"10.1016","volume":"213","author":[{"given":"Makoto","family":"Kashimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirou","family":"Tadokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2016.12.023_bib0005","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.semcancer.2013.09.001","article-title":"B-cell receptor signaling as a driver of lymphoma development and evolution","volume":"23","author":"Niemann","year":"2013","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.prp.2016.12.023_bib0010","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.semcancer.2013.09.003","article-title":"Antigens in lymphoma development\u2013current knowledge and future directions","volume":"23","author":"Rosenquist","year":"2013","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.prp.2016.12.023_bib0015","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the interlymph consortium","volume":"111","author":"Ekstr\u00f6m Smedby","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.prp.2016.12.023_bib0020","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/ijc.24287","article-title":"Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies","volume":"125","author":"Anderson","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.12.023_bib0025","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","article-title":"Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2016.12.023_bib0030","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1182\/blood.V99.9.3376","article-title":"In situ localization of follicular lymphoma: description and analysis by laser capture microdissection","volume":"99","author":"Cong","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.prp.2016.12.023_bib0035","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/01.pas.0000155152.56736.06","article-title":"High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia","volume":"29","author":"Went","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2016.12.023_bib0040","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/10428199509051701","article-title":"p53 expression in non-Hodgkin's lymphomas: a marker of p53 inactivation","volume":"17","author":"Piris","year":"1995","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2016.12.023_bib0045","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1182\/blood-2010-06-275818","article-title":"Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities","volume":"117","author":"Marcucci","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.prp.2016.12.023_bib0050","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/ni1542","article-title":"Follicular shuttling of marginal zone B cells facilitates antigen transport","volume":"9","author":"Cinamon","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.prp.2016.12.023_bib0055","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nature11738","article-title":"Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress","volume":"493","author":"Arnon","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.prp.2016.12.023_bib0060","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1182\/blood-2010-10-299628","article-title":"How I treat: diagnosing and managing in situ lymphoma","volume":"117","author":"Carbone","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.prp.2016.12.023_bib0065","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3109\/10428194.2013.807926","article-title":"Emerging issues after the recognition of in situ follicular lymphoma","volume":"55","author":"Carbone","year":"2014","journal-title":"Leuk. Lymphoma"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816301212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816301212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T04:54:33Z","timestamp":1536123273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033816301212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0344033816301212"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2016.12.023","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Follicular lymphoma in situ in the spleen of a patient with autoimmune hemolytic anemia and carrying HCV was associated with more clonal B-cells than t(14;18) positive B-cells","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2016.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}